Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Orchestra BioMed Holdings, Inc., €16k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Chris Cleary: trading record in brief
Chris Cleary is a declared insider of Orchestra BioMed Holdings, Inc., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 3 February 2025 and the latest from 12 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 August 2026: a share grant of €16k, in Orchestra BioMed Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Chris Cleary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,238 shares@ US$4.42Common Stock, par value $0.0001 per shareSEC:0001104659-26-097174:0
3,510 sharesCommon Stock, par value $0.0001 per shareSEC:0001104659-26-077777:0
676 shares@ US$3.71100.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-011533:0
15,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075783:0
12,422 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-063103:0
10,155 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-009678:0
6 of 6 declarations
